• vcard
  • Education
    • J.D., cum laude, Boston University School of Law, 2018
    • B.A., cum laude, College of the Holy Cross, 2013

Danny provides legal advice to emerging growth companies in a variety of stages of the business life cycle. His practice focuses on advising companies on a wide array of corporate matters, including formation, financing, mergers and acquisitions and general corporate governance matters. Danny helps the legal and business teams to anticipate and address challenges that a growing company encounters and identify available options to help ensure the client’s business is on the most successful path.

Represented biotechnology company in its $1.7 billion acquisition of gene therapy manufacturing company.